CHRISTUS St. Francis Cabrini Hospital
3330 Masonic Dr, Alexandria, LA · Christushealth · · NPI 1639160799
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $124.63 – $229.25 | 16 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $549.85 – $549.85 | 1 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $721.33 – $809.66 | 15 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $129.28 – $210.48 | 2 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $3.04 – $6.57 | 3 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.24 – $2.24 | 1 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $1.78 – $2.20 | 16 |
| Inj meropenem (wg crit care) HCPCS J2183 | $90.95 | $349.80 | $1.54 – $1.73 | 15 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $1.06 – $3.53 | 3 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.52 – $0.52 | 1 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $36.82 – $47.50 | 15 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $226.82 – $254.60 | 16 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $23.51 – $26.39 | 15 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $9.31 – $20.53 | 3 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $8.01 – $8.01 | 1 |
| Inj multihance HCPCS A9577 | not published | not published | $1.94 – $5.14 | 3 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $1.92 – $4.92 | 3 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.57 – $0.57 | 1 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $9.90 – $71.21 | 3 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $549.94 – $672.06 | 16 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | $347.36 | $1,336.00 | $622.21 – $1,649.01 | 16 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.02 – $2.27 | 15 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $88.44 – $99.26 | 15 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $483.29 – $4,572.76 | 19 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $483.29 – $4,572.76 | 19 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $1,066.68 – $2,585.47 | 2 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | not published | not published | $33.99 – $83.96 | 3 |
| Inj ogivri 10 mg HCPCS Q5114 | $10,366.61 | $39,871.56 | $48.32 – $58.50 | 16 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $53.05 – $62.48 | 2 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $1.23 – $1.39 | 15 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $355.71 – $399.27 | 15 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $3.63 – $4.14 | 16 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $3.63 – $4.10 | 16 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,240,493.67 – $2,514,839.83 | 15 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $24.58 – $58.50 | 16 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $55.69 – $62.51 | 15 |
| Inj pantoprazole(hikma) 40mg HCPCS J2471 | not published | not published | $8.27 – $8.27 | 1 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $64.42 – $72.30 | 15 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $486.75 – $558.23 | 16 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $92.13 – $107.53 | 16 |
| Inj, pedmark, 100 mg HCPCS J0208 | not published | not published | $89.49 – $100.45 | 15 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $136.45 – $153.15 | 15 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $23.03 – $203.65 | 16 |
| Inj, pegulicianine, 1 mg HCPCS A9615 | not published | not published | $34.97 – $39.25 | 15 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $49.13 – $55.14 | 15 |
| Inj pemetrexed (accord) 10mg HCPCS J9296 | not published | not published | $9.07 – $10.19 | 15 |
| Inj pemetrexed ditromethamin HCPCS J9323 | not published | not published | $4.97 – $11.04 | 15 |
| Inj pemetrexed, hospira 10mg HCPCS J9294 | not published | not published | $2.09 – $2.68 | 15 |
| Inj pemetrexed (sandoz) 10mg HCPCS J9297 | not published | not published | $1.19 – $1.19 | 1 |
| Inj pemetrexed (teva) 10mg HCPCS J9314 | not published | not published | $6.65 – $7.47 | 15 |
| Inj, pemivibart, 4500 mg HCPCS Q0224 | not published | not published | $6,978.51 – $6,978.51 | 1 |
| Inj, pemrydi rtu, 10 mg HCPCS J9324 | not published | not published | $76.57 – $85.94 | 15 |
| Inj perflexane lip micros,ml HCPCS Q9955 | not published | not published | $15.39 – $32.73 | 2 |
| Inj peritoneal venous shunt CPT 49427 | not published | not published | $2,473.00 – $2,473.00 | 1 |
| Inj., perseris, 0.5 mg HCPCS J2798 | not published | not published | $11.37 – $12.76 | 16 |
| Inj plasminogen tvmh 1mg HCPCS J2998 | not published | not published | $30.31 – $34.02 | 15 |
| Inj., plazomicin, 5 mg HCPCS J0291 | not published | not published | $3.33 – $3.74 | 16 |
| Inj pozelimab-bbfg, 1 mg HCPCS J9376 | not published | not published | $110.08 – $110.08 | 1 |
| Inj proc ankle arthr CPT 27648 | not published | not published | $1,330.55 – $2,473.00 | 2 |
| Inj proc elbow arthro CPT 24220 | $225.16 | $866.00 | $1,330.55 – $2,473.00 | 2 |
| Inj proc for lymphang CPT 38790 | not published | not published | $2,473.00 – $2,473.00 | 1 |
| Inj proc lumbr disk ea lvl CPT 62290 | not published | not published | $2,473.00 – $4,695.41 | 2 |
| Inj proc myelogram lumbar CPT 62284 | $642.98 | $2,473.00 | $1,330.55 – $2,473.00 | 2 |
| Inj proc sialogram CPT 42550 | not published | not published | $2,473.00 – $2,473.00 | 1 |
| Inj progesterone per 50 mg HCPCS J2675 | not published | not published | $0.77 – $3.61 | 3 |
| Inj prohance multipack HCPCS A9576 | not published | not published | $1.56 – $4.27 | 3 |
| Inj protirelin per 250 mcg HCPCS J2725 | not published | not published | $24.40 – $64.22 | 2 |
| Inj recombin esperoct per iu HCPCS J7204 | not published | not published | $2.01 – $2.29 | 16 |
| Inj, releuko 1 mcg HCPCS Q5125 | not published | not published | $0.42 – $0.47 | 15 |
| Inj retacrit esrd on dialysi HCPCS Q5105 | $1,219.62 | $4,690.84 | $0.70 – $0.90 | 16 |
| Inj retro urethrocysto CPT 51610 | not published | not published | $677.30 – $2,473.00 | 2 |
| Inj, rimabotulinumtoxinb HCPCS J0587 | not published | not published | $12.11 – $13.60 | 16 |
| Inj roctavian ml 2x10^13vc g HCPCS J1412 | not published | not published | $10,876.83 – $12,208.69 | 15 |
| Inj., rolapitant, 0.5 mg HCPCS J2797 | not published | not published | $0.95 – $0.95 | 1 |
| Inj romidepsin non-lyo 0.1mg HCPCS J9318 | not published | not published | $26.59 – $34.54 | 16 |
| Inj, rykindo, 0.5 mg HCPCS J2801 | not published | not published | $12.14 – $13.63 | 15 |
| Inj scleros sol mult veins CPT 36471 | not published | not published | $147.00 – $906.14 | 16 |
| Inj scleros sol sgl vein CPT 36470 | $137.80 | $530.00 | $147.00 – $906.14 | 16 |
| Inj, sculptra, 0.5mg HCPCS Q2028 | not published | not published | $0.73 – $1.05 | 16 |
| Inj sebelipase alfa 1 mg HCPCS J2840 | not published | not published | $493.14 – $564.52 | 16 |
| Inj secretin synthetic human HCPCS J2850 | not published | not published | $35.44 – $44.54 | 16 |
| Inj secukinumab intrav 1mg HCPCS J3247 | not published | not published | $16.52 – $18.55 | 15 |
| Inj, sezaby, 1 mg HCPCS J2561 | not published | not published | $0.61 – $0.68 | 15 |
| Inj, spesolimab-sbzo, 1 mg HCPCS J1747 | not published | not published | $57.26 – $64.27 | 15 |
| Inj(s) sclerosant spider veins limb/trunk CPT 36468 | $145.60 | $560.00 | $147.00 – $492.57 | 16 |
| Inj sulf hexa lipid microsph HCPCS Q9950 | not published | not published | $20.18 – $52.49 | 3 |
| Inj, susvimo 0.1 mg HCPCS J2779 | not published | not published | $75.01 – $84.19 | 15 |
| Inj, sutimlimab-jome, 10 mg HCPCS J1302 | not published | not published | $16.91 – $18.98 | 15 |
| Inj. tagraxofusp-erzs 10 mcg HCPCS J9269 | not published | not published | $315.91 – $354.60 | 16 |
| Inj, taliglucerace alfa 10 u HCPCS J3060 | not published | not published | $38.80 – $43.66 | 16 |
| Inj teclistamab cqyv 0.5 mg HCPCS J9380 | not published | not published | $30.34 – $34.06 | 15 |
| Inj tedizolid phosphate HCPCS J3090 | not published | not published | $1.69 – $1.89 | 16 |
| Inj teplizumab mzwv 5 mcg HCPCS J9381 | not published | not published | $34.71 – $38.96 | 15 |
| Inj. teprotumumab-trbw 10 mg HCPCS J3241 | not published | not published | $316.48 – $363.19 | 16 |
| Inj testostero enanthate 1mg HCPCS J3121 | not published | not published | $0.05 – $0.10 | 3 |
| Inj testosterone cypionate HCPCS J1071 | not published | not published | $0.03 – $0.07 | 3 |
| Inj theophylline per 40 mg HCPCS J2810 | not published | not published | $0.42 – $1.11 | 3 |
| Inj thrc fascial pln blk bi w/wo image CPT 64468 | not published | not published | $2,473.00 – $2,473.00 | 1 |
| Inj thrc fascial pln blk uni w/wo image CPT 64466 | not published | not published | $2,473.00 – $2,473.00 | 1 |
| Inj. tigecycline (accord) HCPCS J3244 | not published | not published | $2.81 – $2.81 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.